Evidence map›Paper›PMID 41948087›Full record

ArticleThe mental health clinician2026

Survey of local patterns of fentanyl exposure and harm reduction strategies in the Southeastern United States.

Kaitlyn E Tenn, Sophie Robert, Brianne Mosley, Christine Rarrick

Abstract read
In one paragraph

Article in The mental health clinician, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kaitlyn E Tenn(Corresponding author) Postgraduate Year Two Psychiatric Pharmacy Resident, Medical University of South Carolina Health, Charleston, South Carolina, kaitlyn.tenn@gmail.com.ORCID https://orcid.org/0009-0005-6014-2152
Sophie RobertPsychiatric Clinical Pharmacy Specialist, Medical University of South Carolina Health, Charleston, South Carolina.ORCID https://orcid.org/0000-0003-4221-0252
Brianne MosleyPsychiatric Clinical Pharmacy Specialist, Medical University of South Carolina Health, Charleston, South Carolina.ORCID https://orcid.org/0000-0001-7216-3739
Christine RarrickInpatient Pharmacy Clinical Manager, Medical University of South Carolina Health, Charleston, South Carolina.ORCID https://orcid.org/0000-0002-8906-9332

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Fentanyl, a synthetic opioid, is frequently found as a contaminant in illicit substances, significantly increasing overdose risk. A growing trend toward intentional fentanyl use further complicates the opioid crisis. This study aimed to identify patterns of local fentanyl use and contamination and evaluate harm-reduction interventions provided by psychiatric teams to patients at high risk of opioid overdose. Methods: This observational study combined prospective surveys with retrospective chart review. Adults with a positive fentanyl urine drug screen within 6 months of a psychiatric hospitalization or emergency department encounter were eligible. Participants completed a 10-question survey on substance use patterns, fentanyl risk awareness, and willingness to engage with harm-reduction tools. Electronic health records were reviewed upon patient discharge for demographic and clinical data, including prescribed harm reduction interventions. Results: Eighteen participants completed the survey; 77.8% were male with a mean age of 41 years. Intentional fentanyl use was reported by 77.8% of participants. Commonly codetected substances included amphetamines (44.4%), cannabinoids (38.9%), cocaine (33.3%), and other opioids (27.8%). Whereas more than 90% recognized the overdose risk from fentanyl, nearly half did not perceive themselves to be at personal risk. Most participants were discharged with naloxone (88.9%) and/or prescribed medication for opioid use disorder. Willingness to use fentanyl test strips was high (72.2%). Discussion: The findings of this study underscore the need for the increased availability of harm-reduction strategies, including fentanyl detection tools and tailored education, to address gaps in overdose risk perception and enhance patient safety.

Indexed as

fentanylfentanyl test stripsharm reduction strategiesmedication for opioid use disordernaloxoneNarcanopioid use disorderoverdose preventionsubstance use disorder

Identifiers

PMID41948087
PMCPMC13051534

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.